GSK PLC (GSK)
Clinical trial NCT05145816 updates: 1. completion date: 2026-09-01 → 2027-09-01 2. primary completion date: 2026-03-01 → 2027-03-01
Clinical trial NCT05145816 updates: 1. completion date: 2026-09-01 → 2027-09-01 2. primary completion date: 2026-03-01 → 2027-03-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical